Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.

Cancer Lett 2007 Jun 29;250(2):323-8. Epub 2006 Nov 29.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

Avemar (MSC) is a nontoxic fermented wheat germ extract demonstrated to significantly improve the survival rate in patients suffering from various malignancies. We investigated its effects in human HL-60 promyelocytic leukemia cells. After 24, 48, and 72 h of incubation, Avemar inhibited the growth of HL-60 cells with IC50 values of 400, 190, and 160 microg/ml, respectively. Incubation with MSC caused dose-dependent induction of apoptosis in up to 85% of tumor cells. In addition, Avemar attenuated the progression from G2-M to G0-G1 phase of the cell cycle and was also found to significantly reduce the in situ activity of ribonucleotide reductase, the key enzyme of de novo DNA synthesis. We conclude that Avemar exerts a number of beneficial effects which could support conventional chemotherapy of human malignancies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2006.10.018DOI Listing
June 2007
13 Reads

Publication Analysis

Top Keywords

ribonucleotide reductase
8
wheat germ
8
promyelocytic leukemia
8
hl-60 promyelocytic
8
human hl-60
8
leukemia cells
8
germ extract
8
fermented wheat
8
nontoxic fermented
8
avemar
5
85% tumor
4
induction apoptosis
4
apoptosis 85%
4
progression g2-m
4
cells addition
4
addition avemar
4
avemar attenuated
4
attenuated progression
4
tumor cells
4
msc caused
4

Similar Publications